Europe risks missing target to eliminate viral hepatitis by 2030
While Europe has made steady progress in preventing hepatitis B and C, with the prevalence of hepatitis B…
Occult hepatitis B mutations drive liver cancer growth via Akt mTOR pathway
Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar of…
Combination strategy may optimize interferon-based therapy for chronic hepatitis B
Background and objectives Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen…
Postpartum mothers more likely to be cured of hepatitis C with bedside treatment
Hepatitis C, a bloodborne virus that damages the liver, can cause cirrhosis, liver cancer, liver failure and death…